In a double blinded randomised study, daily injections of semaglutide (0.4 mg) in obese patients resulted in an average of 14% decrease in body weight, over placebo, after a year
Research into safety, efficacy, and specific needs in these demographics will ensure comprehensive care
Mounjaro is not currently approved for this indication
Here's exactly how the legal process works, who qualifies, what to watch for, and what happens from intake to delivery
One in five people taking retatrutide 12mg developed abnormal touch sensations tingling, numbness, uncomfortable feelings when touched
Recent clinical trials demonstrated that SGLT2 inhibitors and GLP-1RAs bring beneficial effects on the cardiorenal outcomes of T2D subjects who are at high risk for CVD